跳至主要内容
临床试验/NCT02592720
NCT02592720Unknown4 期

Intracoronary Cocktail Injection Improves Outcomes of Fractional Flow Reserve Guided Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrom (ACS)

Xijing Hospital1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2015年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
500
试验地点
1
主要终点
Major adverse cardiac events

研究概览

简要总结

This is a randomized, single blind, controlled study of intracoronary cocktail injection before fractional flow reserve (FFR) measurement when guiding percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS).

详细描述

This is a randomized, single blind, controlled study of intracoronary cocktail injection before fractional flow reserve (FFR) measurement when guiding percutaneous coronary intervention (PCI) in patients with acute coronary syndrome (ACS). Patients with ACS will be randomized into the cocktail plus FFR guided group or the QCA guided group. The primary outcome of the cocktail II study is the composite of death, myocardial infarction, class IV heart failure and target vessel revascularization within 1 year. The secondary outcome of the cocktail II study include left ventricular function, quality of life, stroke or life-threatening bleeding within 1 year.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with a clinical diagnosis of recent ACS within 5 days

排除标准

  • haemodynamic instability
  • intolerance to anti-platelet drugs
  • ineligible for coronary revascularization
  • a treatment plan for non-coronary heart surgery (e.g. valve surgery)
  • a history of prior PCI or CABG
  • angiographic evidence of severe (e.g. diffuse calcification) or mild (<30% severity) coronary disease
  • a life expectancy less than 1 year
  • adenosine allergy

研究组 & 干预措施

Cocktail plus FFR guided group

Experimental

Intracoronary cocktail injection before fractional flow reserve (FFR) measurement. Percutaneous Coronary Intervention (PCI) strategy is decided by FFR value in patients with acute coronary syndrome (ACS).

干预措施: cocktail (Drug)

Cocktail plus FFR guided group

Experimental

Intracoronary cocktail injection before fractional flow reserve (FFR) measurement. Percutaneous Coronary Intervention (PCI) strategy is decided by FFR value in patients with acute coronary syndrome (ACS).

干预措施: FFR (Device)

QCA guided group

Placebo Comparator

Percutaneous Coronary Intervention (PCI) strategy is decided by QCA value in patients with acute coronary syndrome (ACS).

干预措施: QCA guided group (Device)

结局指标

主要结局

Major adverse cardiac events

时间窗: 1 year

number of participants with death, myocardial infarction or class IV heart failure and target vessel revascularization revascularization

次要结局

  • stroke(1 year)
  • Seattle Angina Questionnaire scores(1 year)
  • left ventricular function(1 year)
  • Canadian Cardiovascular Society (CCS) Functional Angina classification(1 year)
  • 6-minute walk distance (6MWD)(1 year)

研究者

发起方
Xijing Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

sunddong

Principal Investigator

Xijing Hospital

研究点 (1)

Loading locations...

相似试验